Safety and pharmacokinetics of subcutaneous administration of broadly neutralizing anti-HIV-1 monoclonal antibodies (bNAbs), given to HIV-1 exposed, uninfected neonates and infants: study protocol for a phase I trial.

Autor: Goga A; HIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa.; Department of Paediatrics and Child Health, University of Pretoria, Pretoria, South Africa., Ramraj T; HIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa., Naidoo L; HIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa., Daniels B; HIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa., Matlou M; HIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa., Chetty T; HIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa., Dassaye R; HIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa., Ngandu NK; HIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa., Galli L; Viral Evolution and Transmission Unit, IRCCS Ospedale San Raffaele s.r.l., Milan, Italy., Reddy T; Biostatistics Research Unit, South African Medical Research Council, Durban, South Africa., Seocharan I; Biostatistics Research Unit, South African Medical Research Council, Durban, South Africa., Ndlangamandla Q; Biostatistics Research Unit, South African Medical Research Council, Durban, South Africa., September Q; HIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa., Ngcobo N; HIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa., Reddy M; HIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa., Cafun-Naidoo T; HIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa., Woeber K; HIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa., Jeenarain N; HIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa., Imamdin R; HIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa., Maharajh K; HIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa., Ramjeth A; HIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa., Bhengu T; HIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa., Clarence E; HIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa., Van de Perre P; Pathogenesis and Control of Chronic and Emerging Infections, University of Montpellier, INSERM, Etablissement Français du Sang; CHU Montpellier, Montpellier, France., Tylleskär T; Centre for International Health, Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway., Nagot N; Pathogenesis and Control of Chronic and Emerging Infections, University of Montpellier, INSERM, Etablissement Français du Sang; CHU Montpellier, Montpellier, France., Moles JP; Pathogenesis and Control of Chronic and Emerging Infections, University of Montpellier, INSERM, Etablissement Français du Sang; CHU Montpellier, Montpellier, France., Moore PL; SA MRC Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Center for HIV and STIs, National Institute for Communicable Diseases a Division of the National Health Laboratory Service, Johannesburg, South Africa.; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa., Mkhize NN; SA MRC Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Center for HIV and STIs, National Institute for Communicable Diseases a Division of the National Health Laboratory Service, Johannesburg, South Africa., Gama L; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institute of Health, Bethesda, USA., Dispinseri S; Viral Evolution and Transmission Unit, IRCCS Ospedale San Raffaele s.r.l., Milan, Italy., Biswas P; Viral Evolution and Transmission Unit, IRCCS Ospedale San Raffaele s.r.l., Milan, Italy., Scarlatti G; Viral Evolution and Transmission Unit, IRCCS Ospedale San Raffaele s.r.l., Milan, Italy. scarlatti.gabriella@hsr.it.

Publikováno v: BMC infectious diseases [BMC Infect Dis] 2024 Jul 20; Vol. 24 (1), pp. 712. Date of Electronic Publication: 2024 Jul 20.

Mixed-methods cross-sectional study of the prevention of vertical HIV transmission program users unaware of male partner's HIV status, in six South African districts with a high antenatal HIV burden.

Autor: Mmotsa TM; HIV and other Infectious Diseases Research Unit, South African Medical Research Council, Cape Town, South Africa., Magasana V; HIV and other Infectious Diseases Research Unit, South African Medical Research Council, Cape Town, South Africa., Nsibande DF; HIV and other Infectious Diseases Research Unit, South African Medical Research Council, Cape Town, South Africa., Buthelezi M; HIV and other Infectious Diseases Research Unit, South African Medical Research Council, Cape Town, South Africa., Dassaye R; HIV and other Infectious Diseases Research Unit, South African Medical Research Council, Cape Town, South Africa., Rodriguez VJ; Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.; Department of Psychology (Clinical/Community Division), University of Illinois at Urbana-Champaign, Champaign, IL, United States of America., Jones DL; Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA., Goga AE; HIV and other Infectious Diseases Research Unit, South African Medical Research Council, Cape Town, South Africa.; Department of Paediatrics and Child Health, University of Pretoria, Pretoria, South Africa., Ngandu NK; HIV and other Infectious Diseases Research Unit, South African Medical Research Council, Cape Town, South Africa. Nobubelo.Ngandu@mrc.ac.za.

Publikováno v: BMC public health [BMC Public Health] 2023 Oct 12; Vol. 23 (1), pp. 1988. Date of Electronic Publication: 2023 Oct 12.

Characterization and functional evaluation of goat PDX1 regulatory modules through comparative analysis of conserved interspecies homologs.

Autor: Rezaei, Naeimeh¹ (AUTHOR), Dormiani, Kianoush¹ (AUTHOR) k_dormiani@royaninstitute.org, Kiani-Esfahani, Abbas¹ (AUTHOR), Mirdamadian, Somayeh¹ (AUTHOR), Rahmani, Mohsen² (AUTHOR), Jafarpour, Farnoosh² (AUTHOR), Nasr-Esfahani, Mohammad Hossein^1,2 (AUTHOR) mh.nasr-esfahani@royaninstitute.org

Publikováno v: Scientific Reports. 11/5/2024, Vol. 14 Issue 1, p1-13. 13p.

Estimating prevalence and incidence of sexually transmitted infections among South African women: Implications of combined impacts of risk factors.

Autor: Wand H; Kirby Institute, University of New South Wales, Kensington, Australia., Reddy T; Biostatistics Unit, South African Medical Research Council, Durban, South Africa., Dassaye R; HIV Prevention Unit, South African Medical Research Council, Durban, South Africa., Moodley J; HIV Prevention Unit, South African Medical Research Council, Durban, South Africa., Naidoo S; HIV Prevention Unit, South African Medical Research Council, Durban, South Africa., Ramjee G; HIV Prevention Unit, South African Medical Research Council, Durban, South Africa.

Publikováno v: International journal of STD & AIDS [Int J STD AIDS] 2020 Oct; Vol. 31 (11), pp. 1093-1101. Date of Electronic Publication: 2020 Sep 03.

Seroprevalence of SARS-CoV-2 infection in pediatric patients in a tertiary care hospital setting.

Autor: Pattanakitsakul, Ploy¹ (AUTHOR), Pongpatipat, Chanya² (AUTHOR), Setthaudom, Chavachol³ (AUTHOR), Kunakorn, Mongkol³ (AUTHOR), Sahakijpicharn, Thiantip⁴ (AUTHOR), Visudtibhan, Anannit⁴ (AUTHOR), Apiwattanakul, Nopporn⁴ (AUTHOR), Assawawiroonhakarn, Surapat⁵ (AUTHOR), Pandee, Uthen⁴ (AUTHOR), Techasaensiri, Chonnamet⁴ (AUTHOR), Boonsathorn, Sophida⁴ (AUTHOR), Chaisavaneeyakorn, Sujittra⁴ (AUTHOR) sujittra.cha@mahidol.ac.th

Publikováno v: PLoS ONE. 9/24/2024, Vol. 19 Issue 9, p1-18. 18p.